• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓胸的外科治疗

The surgical management of empyema thoracis.

作者信息

Galea J L, De Souza A, Beggs D, Spyt T

机构信息

Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, Leicester, UK.

出版信息

J R Coll Surg Edinb. 1997 Feb;42(1):15-8.

PMID:9046136
Abstract

Empyema thoracis remains a common thoracic problem with challenging management strategies. We analysed retrospectively 107 consecutive patients treated for empyema thoracic over a 5-year period. The majority of patients (75%) were male with a mean age of 51 years. Common presenting symptoms were cough, dyspnoea, chest pain and pyrexia. The mean duration of pre-admission symptoms was 7.5 weeks. The causes of empyema were pneumonia, malignancy, iatrogenic injury and trauma. The most frequently isolated organism was Streptococcus milleri. In 71% of patients there was an underlying systemic disorder. Forty-nine patients (46%) underwent an unsuccessful therapeutic procedure prior to admission to the surgical units. In the units, 24 patients received closed intercostal chest tube drainage, 14 of whom required further intervention. Two patients were treated with repeated thoracocentesis. The majority of patients underwent a surgical procedure in the first instance: rib resection and drainage (5), decortication (22), and more extensive procedures (9) with only two patients requiring further surgery. The mean post-operative stay was 16 days and the hospital mortality was 13%. We recommend early referral of all empyema patients to thoracic units, where assessment and definitive procedures can be performed with high chances of success and moderate risk of morbidity and mortality.

摘要

脓胸仍然是一个常见的胸部问题,其治疗策略具有挑战性。我们回顾性分析了连续5年中接受脓胸治疗的107例患者。大多数患者(75%)为男性,平均年龄51岁。常见的临床表现为咳嗽、呼吸困难、胸痛和发热。入院前症状的平均持续时间为7.5周。脓胸的病因包括肺炎、恶性肿瘤、医源性损伤和创伤。最常分离出的病原体是米勒链球菌。71%的患者存在潜在的全身性疾病。49例患者(46%)在入住外科病房之前接受的治疗措施未成功。在病房中,24例患者接受了肋间闭式胸腔引流,其中14例需要进一步干预。2例患者接受了反复胸腔穿刺术。大多数患者首先接受了外科手术:肋骨切除及引流(5例)、胸膜剥脱术(22例)以及更广泛的手术(9例),只有2例患者需要再次手术。术后平均住院时间为16天,医院死亡率为13%。我们建议将所有脓胸患者尽早转诊至胸外科病房,在那里可以进行评估和确定性手术,成功几率高,发病和死亡风险适中。

相似文献

1
The surgical management of empyema thoracis.脓胸的外科治疗
J R Coll Surg Edinb. 1997 Feb;42(1):15-8.
2
Presentation and management of empyema thoracis at Lady Reading Hospital Peshawar.白沙瓦雷丁夫人医院脓胸的临床表现与治疗
J Ayub Med Coll Abbottabad. 2004 Jan-Mar;16(1):14-7.
3
Streptococcus milleri infections of the pleural space: operative management predominates.米勒链球菌引起的胸膜腔感染:手术治疗为主。
Am J Surg. 2006 Dec;192(6):817-21. doi: 10.1016/j.amjsurg.2006.08.050.
4
Surgical management of primary empyema of the pleural cavity: outcome of 81 patients.胸腔原发性脓胸的外科治疗:81例患者的治疗结果
Interact Cardiovasc Thorac Surg. 2010 Apr;10(4):565-7. doi: 10.1510/icvts.2009.215004. Epub 2010 Jan 6.
5
Video-assisted thoracoscopic decortication for management of postpneumonic pleural empyema.电视辅助胸腔镜剥脱术治疗肺炎后胸膜脓胸
Am J Surg. 2004 Sep;188(3):321-4. doi: 10.1016/j.amjsurg.2004.06.009.
6
Treatment of post-pneumonic empyema thoracis.肺炎后脓胸的治疗。
Thorac Cardiovasc Surg. 2003 Dec;51(6):338-41. doi: 10.1055/s-2003-45421.
7
Culture-positive thoracic empyema in adults.成人培养阳性的胸腔积脓
Med J Malaysia. 1990 Jun;45(2):169-76.
8
Early decortication in childhood empyema thoracis.儿童脓胸的早期胸膜剥脱术。
Acta Chir Belg. 2007 Mar-Apr;107(2):225-7.
9
Management of thoracic empyema: review of 112 cases.胸腔积脓的治疗:112例病例回顾
Acta Med Iran. 2012;50(3):203-7.
10
Risk factors in surgical management of thoracic empyema in elderly patients.老年患者胸腔积液外科治疗的危险因素
ANZ J Surg. 2008 Jun;78(6):445-8. doi: 10.1111/j.1445-2197.2008.04532.x.

引用本文的文献

1
BTS guidelines for the management of pleural infection.英国胸科学会胸膜感染管理指南。
Thorax. 2003 May;58 Suppl 2(Suppl 2):ii18-28. doi: 10.1136/thorax.58.suppl_2.ii18.